The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCδ and proteasome-dependent regulation of Mcl-1 expression-Reference-Cited by-同舟云学术

The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCδ and proteasome-dependent regulation of Mcl-1 expression

Published:2009-07-06 Issue:37 Volume:28 Page:3261-3273
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Baudot A D,Jeandel P Y,Mouska X,Maurer U,Tartare-Deckert S,Raynaud S D,Cassuto J P,Ticchioni M,Deckert M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2009179.pdf

Reference48 articles.

1. Barragan M, Bellosillo B, Campas C, Colomer D, Pons G, Gil J . (2002). Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood 99: 2969–2976.

2. Caligaris-Cappio F, Hamblin TJ . (1999). B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 17: 399–408.

3. Chen L, Apgar J, Huynh L, Dicker F, Giago-McGahan T, Rassenti L et al. (2005). ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood 105: 2036–2041.

4. Chen L, Juszczynski P, Takeyama K, Aguiar RC, Shipp MA . (2006). Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation. Blood 108: 3428–3433.

5. Chen L, Monti S, Juszczynski P, Daley J, Chen W, Witzig TE et al. (2008). SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 111: 2230–2237.

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents;Expert Opinion on Investigational Drugs;2024-08-11

2. B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy;Leukemia & Lymphoma;2024-04-15

3. An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases;International Journal of Molecular Sciences;2023-12-18

4. The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer;British Journal of Cancer;2022-12-22

5. Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition;Cancer Research;2022-11-21